BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Negrut N, Bungau S, Behl T, Khan SA, Vesa CM, Bustea C, Nistor-Cseppento DC, Rus M, Pavel FM, Tit DM. Risk Factors Associated with Recurrent Clostridioides difficile Infection. Healthcare (Basel) 2020;8:E352. [PMID: 32967323 DOI: 10.3390/healthcare8030352] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Fitero A, Bungau SG, Tit DM, Endres L, Khan SA, Bungau AF, Romanul I, Vesa CM, Radu A, Tarce AG, Bogdan MA, Nechifor AC, Negrut N. Comorbidities, Associated Diseases, and Risk Assessment in COVID-19—A Systematic Review. International Journal of Clinical Practice 2022;2022:1-24. [DOI: 10.1155/2022/1571826] [Reference Citation Analysis]
2 Mattana M, Tomasello R, Cammarata C, Di Carlo P, Fasciana T, Giordano G, Lucchesi A, Siragusa S, Napolitano M. Clostridium difficile Induced Inflammasome Activation and Coagulation Derangements. Microorganisms 2022;10:1624. [DOI: 10.3390/microorganisms10081624] [Reference Citation Analysis]
3 Yang Z, Liu X, Wu Y, Peng J, Wei H. Effect of the Microbiome on Intestinal Innate Immune Development in Early Life and the Potential Strategy of Early Intervention. Front Immunol 2022;13:936300. [DOI: 10.3389/fimmu.2022.936300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Jachowicz E, Pac A, Różańska A, Gryglewska B, Wojkowska-Mach J. Post-Discharge Clostridioides difficile Infection after Arthroplasties in Poland, Infection Prevention and Control as the Key Element of Prevention of C. difficile Infections. Int J Environ Res Public Health 2022;19:3155. [PMID: 35328843 DOI: 10.3390/ijerph19063155] [Reference Citation Analysis]
5 Nibbering B, Gerding DN, Kuijper EJ, Zwittink RD, Smits WK. Host Immune Responses to Clostridioides difficile: Toxins and Beyond. Front Microbiol. 2021;12:804949. [PMID: 34992590 DOI: 10.3389/fmicb.2021.804949] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 van Prehn J, Reigadas E, Vogelzang EH, Bouza E, Hristea A, Guery B, Krutova M, Norén T, Allerberger F, Coia J, Goorhuis A, van Rossen TM, Ooijevaar RE, Burns K, Scharvik Olesen BR, Tschudin-Sutter S, Wilcox MH, Vehreschild M, Fitzpatrick F, Kuijper EJ; guideline committee of the European Study Group on Clostridioides difficile. European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect 2021:S1198-743X(21)00568-1. [PMID: 34678515 DOI: 10.1016/j.cmi.2021.09.038] [Cited by in Crossref: 49] [Cited by in F6Publishing: 57] [Article Influence: 49.0] [Reference Citation Analysis]
7 van Rossen TM, Ooijevaar RE, Vandenbroucke-Grauls CMJE, Dekkers OM, Kuijper EJ, Keller JJ, van Prehn J. Prognostic factors for severe and recurrent Clostridioides difficile infection: a systematic review. Clin Microbiol Infect 2021:S1198-743X(21)00552-8. [PMID: 34655745 DOI: 10.1016/j.cmi.2021.09.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Negrut N, Aleya L, Behl T, Diaconu CC, Munteanu MA, Babes EE, Toma MM, Bungau S. Epidemiology of botulism in the north-western Romania-a 7-year survey. Environ Sci Pollut Res Int 2021;28:64234-40. [PMID: 34297282 DOI: 10.1007/s11356-021-15576-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Fabbian F, De Giorgi A, Ferro S, Lacavalla D, Andreotti D, Ascanelli S, Volpato S, Occhionorelli S. Post-Operative All-Cause Mortality in Elderly Patients Undergoing Abdominal Emergency Surgery: Role of Charlson Comorbidity Index. Healthcare (Basel) 2021;9:805. [PMID: 34206812 DOI: 10.3390/healthcare9070805] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]